ClinicalTrials.gg
Sign In

Uterine Cervical Neoplasms clinical trials

The registry lists 2,366 studies for Uterine Cervical Neoplasms across more than 10 countries. 677 are recruiting or about to start. 1,630 of them are mainly about Uterine Cervical Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 2,630 studies for Uterine Cervical Neoplasms. How that becomes 2,361 here

This page counts the studies the registry files under Uterine Cervical Neoplasms, and those it files under no condition that list Uterine Cervical Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 2,630Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −10List Uterine Cervical Neoplasms as a condition, but the registry did not file them under itMost often written as “Stage 0 Cervical Cancer” (2), “Cancer Cervix Uterus” (2), and “Cervical Cancer Screening” (2). The registry filed them under other conditions only, most often Uterine Cervical Dysplasia (9) and Papillomavirus Infections (2).
  3. −372Match it another way24 name it in the title, 4 in a keyword, and 344 by a synonym or other text the search reads.
  4. 2,248Counted here and found by its search1 of them list Uterine Cervical Neoplasms in their own words; the registry filed them under no condition.
  5. +113
    Counted here, but its search does not find themThe first 20 of 113.
  6. 2,361The count on this page

Get an email when these change. Save the Uterine Cervical Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
975
Recruiting
474
Status unknown
321
Not yet recruiting
179
Active, not recruiting
168
Terminated
155

Phase

Phase 2
596
Phase 1
381
Phase 3
208
Phase 4
42
Early Phase 1
24

Where

United States
834
China
455
France
147
Canada
139
Italy
101
United Kingdom
91

Who runs them

National Cancer Institute (NCI) (70) · M.D. Anderson Cancer Center (59) · Gynecologic Oncology Group (45) · GlaxoSmithKline (32) · Peking Union Medical College Hospital (30) · Merck Sharp & Dohme LLC (29) · Tata Memorial Hospital (27) · Lei Li (23)

What is being tested here

Drugs under test in Uterine Cervical Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Paclitaxel111546
Cisplatin102079
Pembrolizumab10423
Iparomlimab/Tuvonralimab719
Human Papillomavirus Recombinant Vaccine nonavalent6914
Cadonilimab6112
Camrelizumab6112
Anti-CD70 CAR-expressing T Lymphocytes505
Carboplatin4723
Nivolumab4113

Drug classes tested here Immune checkpoint inhibitors 67 open · Antimitotic agents 12 open · Antibody-drug conjugates (ADCs) 9 open · Tyrosine kinase inhibitors (TKIs) 8 open · Antimetabolites 4 open

Coming up

59phase 3 studies under way
234studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 474 Uterine Cervical Neoplasms studies recruiting now, 243 (51%) set no upper age limit and 191 (40%) stop at 75 or younger. 20 (4%) take children under 18. 338 (71%) are for women only and 0 (0%) for men only; 69 (15%) take healthy volunteers.

Recruiting studies that take each age, of 474
AgeWomenMen
1016 (3%)6 (1%)
18381 (80%)127 (27%)
30460 (97%)133 (28%)
40462 (97%)133 (28%)
50443 (93%)132 (28%)
65425 (90%)132 (28%)
75352 (74%)125 (26%)
85268 (57%)109 (23%)

Across all 2,366 studies, recruiting or not: 39% stop at 75 or younger and 23% at 65; 11% take children; 76% are for women only and <1% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Uterine Cervical Neoplasms studies take

Of 204 phase 2 interventional studies under Uterine Cervical Neoplasms, half reached primary completion within 42 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 148 mo27–70 · 142 studies46 mo29–57 · 84 studies57 mo22–72 · 58 studies
Phase 1/262 mo36–75 · 81 studies62 mo41–75 · 53 studies—
Phase 242 mo29–88 · 204 studies34 mo24–46 · 50 studies46 mo34–99 · 154 studies
Phase 355 mo24–80 · 99 studies34 mo15–55 · 46 studies80 mo48–107 · 53 studies
Phase 457 mo18–86 · 19 studies——
Interventional, no phase33 mo15–71 · 462 studies—32 mo14–71 · 446 studies
Observational58 mo28–158 · 213 studies—58 mo27–158 · 189 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting2

Results posted1

Newly registered10

Show 5 more

Studies

Recruiting first, then most recently updated. Showing 50 of 2,366. Browse all 2,366 → or search them.